Pancreatic Cancer Research

ResearcherNebraska Medical CenterActive in the last 2 years

Reegan Sturgeon

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0002-6743-9723; OpenAlex author ID A5057643226. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2023: 2 papers · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 4

  1. Unlocking the Power of CXCR2 Inhibition to Overcome Gemcitabine Resistance in Pancreatic Cancer. First author DOI 10.1096/fba.2025-00265↗
  2. Neutrophil Dynamics Contribute to Disease Progression and Poor Survival in Pancreatic Cancer. Co-author DOI 10.3390/cancers17213541↗
  3. Small molecule antagonist of CXCR2 and CXCR1 inhibits tumor growth, angiogenesis, and metastasis in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2023.216185↗
  4. Tumor-associated neutrophils in pancreatic cancer progression and metastasis. Co-author PMID 38187037↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Caitlin Molczyk · 3 shared papers, 2023–2026 · strength 0.77
  2. Rakesh K. Singh · 3 shared papers, 2023–2026 · strength 0.77
  3. Sugandha Saxena · 2 shared papers, 2023–2026 · strength 0.49
  4. Surinder K. Batra · 2 shared papers, 2023–2026 · strength 0.49
  5. Rakesh Kumar Singh · 1 shared paper, 2023 · strength 0.31
  6. Namita Bhyravbhatla · 1 shared paper, 2026 · strength 0.30
  7. Rick Bhatia · 1 shared paper, 2026 · strength 0.30
  8. Sushil Kumar · 1 shared paper, 2026 · strength 0.30
  9. Michael Anthony Hollingsworth · 1 shared paper, 2025 · strength 0.28
  10. Paul M. Grandgenett · 1 shared paper, 2025 · strength 0.28
  11. Abhilasha Purohit · 1 shared paper, 2023 · strength 0.18
  12. Dipakkumar R. Prajapati · 1 shared paper, 2023 · strength 0.18
  13. Sushil Kumar K · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.